For the shorts, more trade ideas on stocks that are still early in phase 4 downtrend IMO.
BJ - see more downside, although would like a retest of breakdown for another opportunity however we may not get one, started short small size, looking for $48 zone to cover
WHR - Better setup IMO, broke down then retest and rejected. Looking for $154 zone to cover
Clarus Therapeutics Holdings, Inc. (CRXT) Announced Initiation of Phase 4 Clinical Trial of JATENZO, the first and only FDA-approved oral softgel for testosterone replacement therapy in adult male.
On 3/31/2022 Serge Belanger from Needham & Company LLC brokerage set a Buy Rating for CRXT and a Price Target of $8.00, which is 9 times higher than the current...
Distribution entering Phase 4
Three possible entry scenarios:
1. Break major support and wait for retest
2. H8 imbalance fulfilment under second LPSY as if may or might no able to hold
3. H8 imbalance fulfilment and around first LPSY
***Beware SOW on left could be also a re-accumulations***
![EURUSD: EURUSD [Distribution 3 possible sell plans]](https://s3.tradingview.com/3/3gTof7o2_mid.png "EURUSD [Distribution 3 possible sell plans]")
